Authors: ASIN KE DOMINO EF NIKKEL A SHIOSAKI K

Citation: Ke. Asin et al., THE SELECTIVE DOPAMINE D1 RECEPTOR AGONIST A-86929 MAINTAINS EFFICACYWITH REPEATED TREATMENT IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 454-459

Authors: SHIOSAKI K JENNER P ASIN KE BRITTON DR LIN CW MICHAELIDES M SMITH L BIANCHI B DIDOMENICO S HODGES L HONG YF MAHAN L MIKUSA J MILLER T NIKKEL A STASHKO M WITTE D WILLIAMS M

Citation: K. Shiosaki et al., ABT-431 - THE DIACETYL PRODRUG OF A-86929, A POTENT AND SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST - IN-VITRO CHARACTERIZATION AND EFFECTS IN ANIMAL-MODELS OF PARKINSONS-DISEASE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 150-160

Authors: SHIOSAKI K ASIN KE BRITTON DR GIARDINA WJ BEDNARZ L MAHAN L MIKUSA J NIKKEL A WISMER C

Citation: K. Shiosaki et al., HYPERACTIVITY AND BEHAVIORAL SEIZURES IN RODENTS FOLLOWING TREATMENT WITH THE DOPAMINE D-1 RECEPTOR AGONISTS A-86929 AND ABT-431, European journal of pharmacology, 317(2-3), 1996, pp. 183-190

Authors: ASIN KE NIKKEL A BEDNARZ L DOMINO EF SHIOSAKI K

Citation: Ke. Asin et al., A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE, The FASEB journal, 9(3), 1995, pp. 395-395

Authors: ASIN KE BEDNARZ L NIKKEL A PERNER R

Citation: Ke. Asin et al., ROTATION AND STRIATAL C-FOS EXPRESSION AFTER REPEATED, DAILY TREATMENT WITH SELECTIVE DOPAMINE-RECEPTOR AGONISTS AND LEVODOPA, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1483-1490

Authors: ELLIOTT RL KOPECKA H BENNETT MJ SHUE YK CRAIG R LIN CW BIANCHI BR MILLER TR WITTE DG STASHKO MA ASIN KE NIKKEL A BEDNARZ L NADZAN AM

Citation: Rl. Elliott et al., TETRAPEPTIDE CCK AGONISTS - STRUCTURE-ACTIVITY STUDIES ON MODIFICATIONS AT THE N-TERMINUS, Journal of medicinal chemistry, 37(2), 1994, pp. 309-313